Comparison of dexmedetomidine with chloral hydrate as sedatives for pediatric patients

Abstract

Background: Dexmedetomidine (Dex) and chloral hydrate (CH) are the most frequently used sedative agents in pediatric patients. We aimed to systematically review the literature comparing the efficacy and safety of Dex and CH for sedation in pediatric patients. Methods: Seven electronic databases and 3 clinical trial registry platforms were searched for articles published prior to October 2019. Randomized controlled trials (RCTs) evaluating the efficacy and safety of Dex versus CH for sedation in children were examined by 2 reviewers. The extracted information included the success rate of sedation, sedation latency, sedation duration, sedation recovery time, and adverse events. Moreover, the extracted data included 5 subgroups: the effects of 1, 1.5, 2, 2.5, and 3 μg/kg doses of Dex were compared with the effect of CH on the success rate of sedation. We also formed separate subgroups for different types of adverse events (incidence of vomiting, hypotension, bradycardia, etc). The outcomes were analyzed by Review Manager 5.3 software and are expressed as relative risks (RR) or the mean difference (MD) with the 95% confidence interval (CI). Heterogeneity was assessed with I-squared ( I 2 ) statistics. Results: A total of 15 RCTs involving 2128 children with Dex versus CH for sedation were included in the meta-analysis. The dose range of Dex ranged from 1 to 3 μg/kg. Compared with CH, the Dex group had a significantly higher success rate of sedation (RR = 1.14, 95% CI [1.05, 1.25], I 2 = 79%, P = .003). Additionally, subgroup analysis revealed that there was no significant difference in the success rate of sedation between the CH group and the 1, 1.5, 2.5, and 3 μg/kg Dex groups; only the 2 μg/kg Dex group had a significantly higher success rate than the CH group (RR = 1.15, 95% CI [1.03, 1.29], I 2 = 80%, P = .02). There was no significant difference in the number of subjects who required 2 doses or the duration of sedation between the CH and Dex groups. Furthermore, compared with the Dex group, the CH group had a significantly longer sedation latency (MD = –3.54, 95% CI [–5.94, –1.15], I 2 = 95%, P = .004), sedation recovery time (MD = –30.08, 95% CI [–46.77, –13.39], I 2 = 99%, P = .0004), and total time from sedative administration to discharge (MD = –12.73, 95% CI [–15.48, –9.97], I 2 = 0%, P < .05), as well as a higher number of adverse events in total (RR = 0.25, 95% CI [0.11, 0.61], I 2 = 89%, P = .002). Moreover, the subgroup analysis of adverse events revealed that ...

Preliminary evaluation of the efficacy and safety of brimonidine for general anesthesia

“…Although brimonidine has hypnotic and analgesic effects because it indirectly inhibits the ascending activation system of the reticular structure through the locus coeruleus, it does not block the awakening mechanism while accompanying sleep [ 18 ]. We found that during the hypnotic process elicited by injected administration of brimonidine to rabbits, they would be awakened in a short time by changing their body position and pulling their limbs hard.…”

A Comparison of Brain-State Dynamics across Common Anesthetic Agents in Male Sprague-Dawley Rats

“…Consequently, it is of great interest that CH anesthesia produced a pattern of EEG activity remarkably similar to urethane, as CH is considered an acceptable anesthetic for recovery surgeries [ 57 , 58 ], and indeed is still in use as a clinical sedative primarily for pediatric patients [ 59 ]. This suggests that CH could provide researchers an avenue to perform controlled neurophysiological manipulations under a sleep-like state of CH anesthesia, and then assess behavioral outcomes.…”

Preliminary Evaluation of the Efficacy and Safety of Brimonidine for General Anesthesia

“…Although brimonidine has hypnotic and analgesic effects because it indirectly inhibits the ascending activation system of the reticular structure through the locus coeruleus, it does not block the awakening mechanism while accompanying sleep [23] . We found that during the hypnotic process elicited by injected administration of brimonidine to rabbits, they would be awakened in a short time by changing their body position and pulling their limbs hard.…”